Immunotherapy for Hepatocellular Carcinoma: A 2021 Update
Christo Kole1, Nikolaos Charalampakis2, Sergios Tsakatikas2
1First Department of Surgery, National and Kapodistrian University of Athens, Laikon General Hospital, 115 27 Athens, Greece.
Cancers
|October 6, 2020
Summary
Immunotherapy shows promise for hepatocellular carcinoma (HCC) treatment. Combining immunotherapies or using them with other treatments improves survival rates for liver cancer patients, with tumor microenvironment being a key factor.
Area of Science:
- Hepatology
- Oncology
- Immunology
Background:
- Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality globally.
- Existing treatments for HCC benefit a limited patient subset.
- Immunotherapy offers a novel and effective cancer treatment strategy.
Purpose of the Study:
- To review ongoing clinical trials for immunotherapy in HCC.
- To evaluate the efficacy of immunotherapy for hepatocellular carcinoma.
- To highlight the role of the tumor microenvironment in predicting treatment response.
Main Methods:
- Review of current clinical trials in HCC immunotherapy.
- Analysis of survival data (overall survival and progression-free survival).
- Evaluation of the tumor microenvironment as a predictive marker.
Main Results:
- Combination therapies (immunotherapy + immunotherapy or immunotherapy + other modalities) show improved overall survival (OS) and progression-free survival (PFS).
- Single-agent immunotherapy shows less efficacy compared to combination approaches.
- Tumor microenvironment characteristics are significant predictors of immunotherapy response.
Conclusions:
- Combination immunotherapy strategies represent a promising approach for HCC treatment.
- The tumor microenvironment is a critical factor influencing immunotherapy outcomes in HCC.
- Further research into combination therapies and microenvironment modulation is warranted for HCC management.
Keywords:
adoptive cellular immunotherapycancer vaccineshepatocellular carcinomaimmune checkpoint inhibitorsimmunotherapymicrosatellite instabilityoncolytic virusestumor microenvironmentMore Related Videos
11:08Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
1.5K
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
5.8K
Related Concept Videos
01:27Tumor Immunotherapy
1.3K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.3K
02:57Targeted Cancer Therapies
8.3K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.3K
01:30Cancer Vaccines
852
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
852
02:49Cancer Therapies
9.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.6K
02:56Treatment Resistant Cancers
3.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K